Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
PBF Energy
PBF
$8.56B
| $2.15M | 0.04% |
52,811
-9,594
| -15% | -$399K |
|
602
Wolverine World Wide
WWW
$1.74B
| $2.15M | 0.04% |
197,081
-181
| -0.1% | -$2.41K |
|
603
CALL
KLA
KLAC
$234B
| $2.15M | 0.04% |
57,000
-16,000
| -22% | -$558K |
|
604
Vertiv
VRT
$97.7B
| $2.15M | 0.04% |
157,285
+107,085
| +213% | +$1.43M |
|
605
NorthWestern Energy
NWE
$4.29B
| $2.15M | 0.04% |
36,202
-64,694
| -64% | -$3.53M |
|
606
Popular Inc
BPOP
$10.8B
| $2.15M | 0.04% |
32,349
| – | – |
|
607
iShares MSCI Canada ETF
EWC
$6.91B
| $2.14M | 0.04% |
65,441
-18,654
| -22% | -$618K |
|
608
CALL
Baxter International
BAX
$13.7B
| $2.14M | 0.04% |
+42,000
| New | +$2.26M |
|
|
ACH
609
Accendra Health
ACH
$89.2M
| $2.14M | 0.04% |
+109,605
| New | +$2.14M |
|
610
Constellium
CSTM
$3.66B
| $2.14M | 0.04% |
180,529
-80,831
| -31% | -$945K |
|
611
Aptiv
APTV
$10B
| $2.13M | 0.04% |
22,852
-1,309
| -5% | -$124K |
|
612
CALL
Cigna
CI
$74.3B
| $2.12M | 0.04% |
6,400
+1,000
| +19% | +$316K |
|
|
HES
613
PUT
DELISTED
Hess
HES
| $2.11M | 0.04% |
+14,900
| New | +$2.05M |
|
614
MakeMyTrip
MMYT
$5.65B
| $2.11M | 0.04% |
76,538
+50,786
| +197% | +$1.47M |
|
615
CALL
RTX Corp
RTX
$283B
| $2.11M | 0.04% |
20,900
+8,100
| +63% | +$762K |
|
|
TSE
616
DELISTED
Trinseo
TSE
| $2.1M | 0.04% |
92,412
+15,080
| +20% | +$332K |
|
617
Wyndham Hotels & Resorts
WH
$5.57B
| $2.09M | 0.04% |
29,319
-136,776
| -82% | -$9.67M |
|
618
Sabre
SABR
$848M
| $2.08M | 0.04% |
336,945
+74,207
| +28% | +$414K |
|
619
PUT
C.H. Robinson
CHRW
$16.6B
| $2.08M | 0.04% |
22,700
+17,400
| +328% | +$1.66M |
|
620
CALL
Crown Castle
CCI
$32.4B
| $2.08M | 0.04% |
15,300
+8,900
| +139% | +$1.2M |
|
621
Textron
TXT
$14.3B
| $2.07M | 0.04% |
29,198
-19,054
| -39% | -$1.29M |
|
622
Hilltop Holdings
HTH
$2.22B
| $2.06M | 0.04% |
+68,817
| New | +$1.96M |
|
623
Ubiquiti
UI
$32.7B
| $2.05M | 0.04% |
7,511
-4,928
| -40% | -$1.47M |
|
|
LGAC
624
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
| $2.05M | 0.04% |
203,322
| – | – |
|
625
Gibraltar Industries
ROCK
$1.39B
| $2.05M | 0.04% |
44,669
-14,125
| -24% | -$678K |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.